If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.60
Bid: 82.20
Ask: 83.40
Change: -1.60 (-1.90%)
Spread: 1.20 (1.46%)
Open: 83.00
High: 83.80
Low: 82.60
Prev. Close: 84.20
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AMP8 Water Framework Win with NWG & Trading Update

10 Jan 2024 07:00

RNS Number : 1624Z
Costain Group PLC
10 January 2024
 

 

Costain Group PLC

10 January 2024

Costain AMP8 Framework Agreement with Northumbrian Water Group and Trading Update

Appointment adds to Costain's wins in the new water regulatory cycle

 

Costain Group PLC ("Costain", or the "Company") announces that it has been appointed by Northumbrian Water Group (NWG) to shape, create and deliver its strategic infrastructure upgrade programme. The framework will see contracts awarded with a potential value of up to £670m to Costain during a 12-year period and builds on recent significant wins in the water sector for the Company.

The framework contract will see Costain work with NWG and its partners to shape, create and deliver solutions to meet the strategic needs of its business plan during Asset Management Period 8 (AMP8). The contract starts immediately and will run for a seven-year initial term with an option for a five-year extension.

The work will involve:

· The design, construction and commissioning of new water and wastewater treatment assets, asset renewals, asset modifications, refurbishments and extensions to treatment works.

· Programmes of investigation and delivery work by asset type, geography and/or by specialism.

AMP8 will see the biggest investment in the water industry for decades. In 2023, Costain extended into AMP8 its Managed Service Provider contract with United Utilities and its consultancy work with Yorkshire Water. Costain has also won funding from Ofwat to support innovation projects.

Trading Update

Costain has had a positive trading year in 2023 and expects to deliver adjusted operating profit in line with market expectations. As a result, and reflecting an increase in financial income compared to 2022 and strong working capital management, together with the accumulation of £25.0m of positive working capital timings, Costain has ended 2023 with a net cash position of £164.4m (2022 year-end: £123.8m), significantly higher than market expectations of £128.6m.

Alex Vaughan, CEO, Costain said:

"Costain is a leading business partner to the water industry, ensuring that water companies achieve value for money as they meet the needs of their customers and the regulator during this crucial period for water investment. We are looking forward to supporting Northumbrian Water in this new working relationship, upgrading both its wastewater and water treatment infrastructure to improve people's lives and safeguard the environment. At Costain, we develop solutions by building collaborative and sustainable relationships with our customers, and we are excited to begin this vital work.

"This contract win not only reflects our continued growth in the water sector, but it also reinforces our commitment to improving critical infrastructure in the North-East of England. This includes major upgrades to the region's highways and our carbon capture work in Teesside as part of the East Coast Cluster, generating opportunities for regional suppliers and employment for local people.

"We are also pleased to report that we have had a positive trading year and expect to deliver adjusted operating profit in line with market expectations. Our cash performance has been very strong, driven by continued improved operational performance, an increase in financial income compared to 2022, and ongoing positive working capital timings."

 

Costain will issue its results for the financial year 2023 on 12 March 2024.

Enquiries:

 

Investors and analysts paul.sharma@costain.com

Paul Sharma, Costain +44 (0) 7867 501188

 

Financial media - Headland costain@headlandconsultancy.com

Andy Rivett-Carnac +44 (0) 7968 997 365

Charlie Twigg +44 (0) 7946 494 568

 

Notes to editors

 

Costain helps to improve people's lives by creating connected, sustainable infrastructure that enables people and the planet to thrive. We shape, create and deliver pioneering solutions that transform the performance of the infrastructure ecosystem across the UK's transport, energy, water, and defence markets.

 

We are organised around our customers anticipating and solving their challenges and helping to improve performance. By bringing together our unique mix of construction, consulting and digital experts we engineer and deliver sustainable, efficient and practical solutions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGGMRLFGDZM
Date   Source Headline
29th Nov 20162:42 pmRNSProposed Placing
21st Nov 20167:00 amRNSContract
15th Nov 20167:00 amRNSContract
4th Nov 20161:48 pmRNSDirector/PDMR Shareholding
1st Nov 20169:37 amRNSTotal Voting Rights
31st Oct 20167:00 amRNSTotal Voting Rights
27th Oct 20167:00 amRNSBlock Listing Application
19th Oct 20164:36 pmRNSDividend Declaration - Amendment
18th Oct 20168:00 amRNSDividend - Scrip Alternative
27th Sep 201612:38 pmRNSDirector/PDMR Shareholding
23rd Sep 201611:06 amRNSHolding(s) in Company
22nd Sep 201611:43 amRNSScrip Dividend Reference Price
20th Sep 201612:57 pmRNSHolding(s) in Company
6th Sep 201612:11 pmRNSDirector/PDMR Shareholding
1st Sep 201612:13 pmRNSHolding(s) in Company
30th Aug 20164:28 pmRNSHolding(s) in Company
30th Aug 20164:08 pmRNSHolding(s) in Company
24th Aug 20167:00 amRNSHalf-year Report
11th Jul 201610:16 amRNSDirector Declaration
6th Jul 20167:00 amRNSAcquisition
30th Jun 201612:53 pmRNSDirector/PDMR Shareholding
30th Jun 20168:57 amRNSBlock listing Interim Review
30th Jun 20167:00 amRNSTrading Update
17th Jun 20167:00 amRNSBusiness Briefing
31st May 20169:00 amRNSTotal Voting Rights
17th May 20167:00 amRNSDividend - Scrip Alternative
16th May 20163:03 pmRNSDirector/PDMR Shareholding
5th May 20164:51 pmRNSResult of AGM
5th May 20167:01 amRNSLTIP Listing Application
5th May 20167:00 amRNSAGM Statement
25th Apr 20167:00 amRNSHolding(s) in Company
21st Apr 20162:05 pmRNSScrip Dividend Reference Price
18th Apr 201610:22 amRNSHolding(s) in Company
7th Apr 20167:00 amRNSDirector/PDMR Shareholding
6th Apr 20167:00 amRNSAppointment of Chairman Designate
4th Apr 201610:38 amRNSDirector/PDMR Shareholding
31st Mar 201610:32 amRNSNotice of AGM
2nd Mar 20167:00 amRNSFinal Results
1st Feb 20167:00 amRNSRe Contract
21st Jan 20169:07 amRNSHolding(s) in Company
11th Jan 20167:00 amRNSConfirmation of Contract Award
7th Jan 201612:17 pmRNSHolding(s) in Company
6th Jan 20167:00 amRNSTrading Update
4th Jan 20168:55 amRNSBlocklisting Interim Review
24th Dec 201512:17 pmRNSDirector/PDMR Shareholding
22nd Dec 201511:46 amRNSHolding(s) in Company
22nd Dec 20159:13 amRNSHolding(s) in Company
17th Dec 20157:00 amRNSRe Contract
9th Dec 201511:22 amRNSHolding(s) in Company
1st Dec 20159:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.